Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials

Overview of attention for article published in Frontiers in immunology, May 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 19 X posts from 17 X users, with an upper bound of 37,707 followers.

RT @exosome: I wonder if we could reposition the dendritic cell platform of $NWBO to induce tolerance in conditions such as #MultipleSclero…

RT @exosome: I wonder if we could reposition the dendritic cell platform of $NWBO to induce tolerance in conditions such as #MultipleSclero…

RT @justinkeister5: Dendritic cells are amazing. We’re just beginning to understand the possibilities.

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 15 additional X posts.